Cargando…
Preserved C-reactive protein responses to blood stream infections following tocilizumab treatment for COVID-19
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8363426/ https://www.ncbi.nlm.nih.gov/pubmed/34400218 http://dx.doi.org/10.1016/j.jinf.2021.08.017 |
| _version_ | 1783738350360854528 |
|---|---|
| author | Wey, Emmanuel Q. Bristow, Clare Nandani, Aarti O'Farrell, Bryan Pang, Jay Lanzman, Marisa Yang, Shuang Ho, Soo Mack, Damien Spiro, Michael Balakrishnan, Indran Bhagani, Sanjay Pollara, Gabriele |
| author_facet | Wey, Emmanuel Q. Bristow, Clare Nandani, Aarti O'Farrell, Bryan Pang, Jay Lanzman, Marisa Yang, Shuang Ho, Soo Mack, Damien Spiro, Michael Balakrishnan, Indran Bhagani, Sanjay Pollara, Gabriele |
| author_sort | Wey, Emmanuel Q. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8363426 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | The British Infection Association. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-83634262021-08-15 Preserved C-reactive protein responses to blood stream infections following tocilizumab treatment for COVID-19 Wey, Emmanuel Q. Bristow, Clare Nandani, Aarti O'Farrell, Bryan Pang, Jay Lanzman, Marisa Yang, Shuang Ho, Soo Mack, Damien Spiro, Michael Balakrishnan, Indran Bhagani, Sanjay Pollara, Gabriele J Infect Letter to the Editor The British Infection Association. Published by Elsevier Ltd. 2021-11 2021-08-14 /pmc/articles/PMC8363426/ /pubmed/34400218 http://dx.doi.org/10.1016/j.jinf.2021.08.017 Text en © 2021 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Wey, Emmanuel Q. Bristow, Clare Nandani, Aarti O'Farrell, Bryan Pang, Jay Lanzman, Marisa Yang, Shuang Ho, Soo Mack, Damien Spiro, Michael Balakrishnan, Indran Bhagani, Sanjay Pollara, Gabriele Preserved C-reactive protein responses to blood stream infections following tocilizumab treatment for COVID-19 |
| title | Preserved C-reactive protein responses to blood stream infections following tocilizumab treatment for COVID-19 |
| title_full | Preserved C-reactive protein responses to blood stream infections following tocilizumab treatment for COVID-19 |
| title_fullStr | Preserved C-reactive protein responses to blood stream infections following tocilizumab treatment for COVID-19 |
| title_full_unstemmed | Preserved C-reactive protein responses to blood stream infections following tocilizumab treatment for COVID-19 |
| title_short | Preserved C-reactive protein responses to blood stream infections following tocilizumab treatment for COVID-19 |
| title_sort | preserved c-reactive protein responses to blood stream infections following tocilizumab treatment for covid-19 |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8363426/ https://www.ncbi.nlm.nih.gov/pubmed/34400218 http://dx.doi.org/10.1016/j.jinf.2021.08.017 |
| work_keys_str_mv | AT weyemmanuelq preservedcreactiveproteinresponsestobloodstreaminfectionsfollowingtocilizumabtreatmentforcovid19 AT bristowclare preservedcreactiveproteinresponsestobloodstreaminfectionsfollowingtocilizumabtreatmentforcovid19 AT nandaniaarti preservedcreactiveproteinresponsestobloodstreaminfectionsfollowingtocilizumabtreatmentforcovid19 AT ofarrellbryan preservedcreactiveproteinresponsestobloodstreaminfectionsfollowingtocilizumabtreatmentforcovid19 AT pangjay preservedcreactiveproteinresponsestobloodstreaminfectionsfollowingtocilizumabtreatmentforcovid19 AT lanzmanmarisa preservedcreactiveproteinresponsestobloodstreaminfectionsfollowingtocilizumabtreatmentforcovid19 AT yangshuang preservedcreactiveproteinresponsestobloodstreaminfectionsfollowingtocilizumabtreatmentforcovid19 AT hosoo preservedcreactiveproteinresponsestobloodstreaminfectionsfollowingtocilizumabtreatmentforcovid19 AT mackdamien preservedcreactiveproteinresponsestobloodstreaminfectionsfollowingtocilizumabtreatmentforcovid19 AT spiromichael preservedcreactiveproteinresponsestobloodstreaminfectionsfollowingtocilizumabtreatmentforcovid19 AT balakrishnanindran preservedcreactiveproteinresponsestobloodstreaminfectionsfollowingtocilizumabtreatmentforcovid19 AT bhaganisanjay preservedcreactiveproteinresponsestobloodstreaminfectionsfollowingtocilizumabtreatmentforcovid19 AT pollaragabriele preservedcreactiveproteinresponsestobloodstreaminfectionsfollowingtocilizumabtreatmentforcovid19 |